Skip to main content
Fig. 2 | BMC Emergency Medicine

Fig. 2

From: Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial

Fig. 2

Distribution of mRS scores at day 90 for GTN versus sham among 274 stroke mimic participants. Comparison of GTN versus sham, adjusted common odds ratio 0.54 (0.34, 0.85), p = 0.008, by ordinal logistic regression, with adjustment for age, sex, pre-morbid modified Rankin Scale, face-arms-speech-time test, pre-treatment SBP, final diagnosis (stroke mimic) and time to randomisation. The effect of treatment for GTN versus sham is shown as adjusted common odds ratio (acOR)

Back to article page